Laboratorios Bago De Bolivia S.a.

What Laboratorios Bago De Bolivia S.a. does

Laboratorios Bagó de Bolivia S.A. is a Bolivian pharmaceutical distribution and commercialization company headquartered in La Paz. Founded in 1976, the company distributes a portfolio of prescription, OTC, dermatological, nutritional, blood-product, and oncology medications on behalf of international principals — including Bayer, SanCor, Ordesa, Octapharma, Leti, Cantabria Labs, Certmedica, and Bioprofarma Bagó — across all major therapeutic categories.

The company operates a national footprint of 11 regional offices (La Paz, Santa Cruz, Cochabamba, Sucre, Trinidad, Tarija, Oruro, Potosí, and El Alto) plus a central warehouse, reaching pharmacies, healthcare providers, and end consumers across Bolivia. Beyond third-party distribution, it has begun building proprietary product lines such as the "Gen Ético" generics brand, and has launched the "Bagó 24/7" digital pharmacy ordering service and "Bagó Sostenible" sustainability initiative. The firm is OEA (Authorized Economic Operator) certified, supporting customs and trade compliance for its import-heavy supply chain.

Laboratorios Bagó de Bolivia is privately held, employs 501-1,000 staff, and generates revenue through product distribution margins on its pharmaceutical portfolio. No revenue figures, funding history, or M&A activity are publicly disclosed. Its customer base spans healthcare providers and pharmacies as the primary channel, with consumers reached through both pharmacy partners and direct channels such as the Bagó 24/7 portal.

Name

Laboratorios Bago De Bolivia S.a.

Legal name

Laboratorios Bagó de Bolivia S.A.

Website

https://bago.com.bo

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

251–500 employees

Short description

Laboratorios Bagó de Bolivia S.A. distributes pharmaceutical products from international brands including Bayer, SanCor, Ordesa, Octapharma, and Leti across Bolivia, operating 11 regional offices and a central warehouse to serve pharmacies, healthcare providers, and consumers across multiple therapeutic categories.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical distribution
• Prescription medications
• Baby nutrition products
• Dermatological care products
• Blood plasma products

Headquarters

HQ city

La Paz

HQ country

Bolivia

HQ region

Latin America

Offices11 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Product Distribution: Distribution of pharmaceutical products from international brands including Bayer, SanCor, Ordesa, Octapharma, Leti, Cantabria Labs, and Bioprofarma Bagó throughout Bolivia through regional offices.

Distribution channels1 record

Marketing channels5 records

Core offering

Laboratorios Bagó de Bolivia develops, manufactures and commercializes pharmaceutical products and related digital ordering services. The company distributes a broad portfolio of pharmaceutical, dermatological, nutritional, baby care, blood plasma, and oncology products from international brands including Bayer, SanCor, Ordesa, Octapharma, Leti, Cantabria Labs, Certmedica, and its own Bioprofarma Bagó line throughout Bolivia via a national network of regional offices.

Differentiator

Problem solved

Functional benefit

Brands

• Bagó 24/7: 24/7 pharmacy service offering
• Bagó Sostenible
• LETI AT-4
• Octapharma Products
• SanCor Bebé
• Colnatur
• Bioprofarma Bagó

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• BayercoreChannel Partner/ Reseller/ DistributorDistribution partnership for Bayer pharmaceutical products including Actron, Aspirin, Redoxon, Cardioaspirina, Gadovist, Ultravist, Urografina, and Progyluton in the Bolivian market.
• SanCorcoreChannel Partner/ Reseller/ DistributorDistribution of SanCor baby formula products including SanCor Bebé Advanced lines (1, 2, 3, and 3+) in liquid and powder formats in Bolivia.
• OrdesacoreChannel Partner/ Reseller/ DistributorDistribution of Ordesa nutritional supplements including Colnatur Beauty, Colnatur Complex, and Colnatur Sport in Bolivia.
• OctapharmacoreChannel Partner/ Reseller/ DistributorDistribution of Octapharma blood products including Albunorm, Fibryga, Octanate, Octanine F, Octaplex, and Panzyga in Bolivia.
• LeticoreChannel Partner/ Reseller/ DistributorDistribution of Leti dermatological products including LETI AT-4 line (Champú, Crema corporal, Crema facial, Crema Intensive, Gel de baño, Leche corporal) for atopic skin care in Bolivia.
• Cantabria LabscoreChannel Partner/ Reseller/ DistributorDistribution of Cantabria Labs dermatological products including Iraltone (hair care), Endocare, Heliocare, Neoretin, and Biretix lines in Bolivia.
• CertmedicaminorChannel Partner/ Reseller/ DistributorDistribution partnership for Certmedica products in the Bolivian pharmaceutical market.
• Bioprofarma BagócoreChannel Partner/ Reseller/ DistributorDistribution of Bioprofarma Bagó branded products including Donataxel, Mitotie, Panataxel, Oxaltie, Sinresor, Idelara, and other oncology medications.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Others

• Grupo Bagó: Argentine pharmaceutical group and apparent ultimate parent/affiliate network for Laboratorios Bagó de Bolivia. Relevant as the upstream manufacturer of Bioprofarma Bagó oncology products and as a strategic/operational reference point for the Bolivian subsidiary's supply relationships.
• Bayer Bolivia: Local subsidiary of Bayer, whose products (Aspirin, Cardioaspirina, Gadovist, Ultravist, Urografina) Laboratorios Bagó distributes in Bolivia. Relevant as both a key principal partner and an upstream player whose own direct-distribution decisions materially affect Laboratorios Bagó's portfolio.

Direct peers

• Droguería Inti: Bolivian pharmaceutical distributor headquartered in La Paz with national reach across retail pharmacies and hospitals. Directly comparable as a private Bolivian pharma wholesaler competing for the same retail and institutional accounts in overlapping therapeutic categories.
• Alfarma: Bolivian pharmaceutical distributor/wholesaler (droguería) supplying pharmacies and healthcare institutions nationally. Directly comparable to Laboratorios Bagó as a national-scale pharmaceutical distributor in the same single-country market with overlapping retail pharmacy customer base.
• Laboratorios La Santé: Latin American pharmaceutical company with established Bolivian operations distributing branded and generic products to pharmacies. Comparable as a regional pharma manufacturer-distributor with Bolivia presence and similar customer segmentation across retail and institutional channels.
• Farmacorp: Major Bolivian pharmacy retail chain with distribution and private-label operations. Comparable as a vertically integrated Bolivian pharma player combining distribution with retail customer access, partially overlapping with Laboratorios Bagó's downstream channel.

Broad incumbents

• Megalabs: Latin American pharmaceutical company with manufacturing and distribution across 18+ countries including Bolivia-region presence. Comparable as a broad regional incumbent in branded generics and specialty pharma with similar customer targeting of retail pharmacy chains.
• Genomma Lab Internacional: Mexican-origin pharmaceutical company with broad LatAm OTC and personal care distribution. Comparable as a regional incumbent operating across OTC, dermatology, and nutritional categories that overlap with several Laboratorios Bagó-distributed lines (Bayer OTC, Cantabria Labs dermo, Colnatur supplements).
• Eurofarma Laboratórios: Brazilian pharmaceutical manufacturer with LatAm-wide distribution footprint spanning branded, generic, and OTC products. Comparable as a broad regional incumbent whose product portfolio and distribution model overlap with Laboratorios Bagó's therapeutic and channel mix.
• Procaps: Latin American pharmaceutical developer and manufacturer with presence across multiple South American markets. Comparable as a regional pharma player operating across therapeutic categories with both branded and generic offerings relevant to emerging-market distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/BagoBolivia
• YouTubeyoutube.com/channel/UCIN5K8picaqF0ZtsdVSEAvQ
• Facebookfacebook.com/saludybienestarbago
• LinkedInbo.linkedin.com/company/laboratorios-bago-de-bolivia
• Instagraminstagram.com/saludybienestarbago

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Bago De Bolivia S.a.